Benefit-risk trade-offs for treatment decisions in moderate-to-severe rheumatoid arthritis: focus on the patient perspective
Crossref DOI link: https://doi.org/10.1007/s00296-017-3760-z
Published Online: 2017-06-16
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Husni, M. Elaine
Betts, Keith A.
Griffith, Jenny
Song, Yan
Ganguli, Arijit
Funding for this research was provided by:
AbbVie
License valid from 2017-06-16